List View

By /

Clear

Displaying 2,326 - 2,350 of 2,995

Gene Therapy in Oncology: Past, Present and Future

Gene Therapy in Oncology: Past, Present and Future

Molecular and Immunotherapy Updates in Colon Cancer

Molecular and Immunotherapy Updates in Colon Cancer

Immunotherapy in HCC

Immunotherapy in HCC

New Approaches And Advances In The Therapy Of Gliomas

New Approaches And Advances In The Therapy Of Gliomas

New Agents after Immunotherapy Resistance

New Agents after Immunotherapy Resistance

What’s New in EGFR, ALK, RET and c-MET

What’s New in EGFR, ALK, RET and c-MET

Neoadjuvant and Adjuvant Immunotherapy

Neoadjuvant and Adjuvant Immunotherapy

Small Cell Lung Cancer

Small Cell Lung Cancer

Updates in Systemic Therapy of Urothelial Cancer

Updates in Systemic Therapy of Urothelial Cancer

PARP Inhibitors in Prostate Cancer- Who, When, and Why (not)

PARP Inhibitors in Prostate Cancer- Who, When, and Why (not)

Sequencing Endocrine Therapy And Targeted Agents For The Treatment Of Hormone Receptor Positive Metastatic Breast Cancer

Sequencing Endocrine Therapy And Targeted Agents For The Treatment Of Hormone Receptor Positive Metastatic Breast Cancer

Antibody Drug Conjugates- New Directions, New Agents!

Antibody Drug Conjugates- New Directions, New Agents!

Advances in the Treatment of High Risk Early Stage Hormone Receptor Positive Breast Cancer

Advances in the Treatment of High Risk Early Stage Hormone Receptor Positive Breast Cancer

Immunotherapy For Triple Negative Breast Cancer Optimal Chemotherapy Partners, New Directors, And Managing Toxicity

Immunotherapy For Triple Negative Breast Cancer Optimal Chemotherapy Partners, New Directors, And Managing Toxicity

Controversies In The Management Of Ovarian Cancer A Focus On First Line Treatment

Controversies In The Management Of Ovarian Cancer A Focus On First Line Treatment

Immunotherapy For Uterine Cancer New Standards For Upfront Treatment For Advanced Or Recurrent Disease

Immunotherapy For Uterine Cancer New Standards For Upfront Treatment For Advanced Or Recurrent Disease

Treating Advanced Or Metastatic Cervical Cancer ADCs, VEGF Inhibitors, And Immunotherapy

Treating Advanced Or Metastatic Cervical Cancer ADCs, VEGF Inhibitors, And Immunotherapy

Melanoma- Have we Hit a Plateau or are we Making Progress

Melanoma- Have we Hit a Plateau or are we Making Progress

Adjuvant Therapy for Renal Cell Carcinoma- Hope or Hype

Adjuvant Therapy for Renal Cell Carcinoma- Hope or Hype

Advancing Precision In Endometrial Carcinoma Molecular Classification And Its Impact On Prognosis And Treatment. Are We Ready

Advancing Precision In Endometrial Carcinoma Molecular Classification And Its Impact On Prognosis And Treatment. Are We Ready

AML- Where Are We Now and Where Are We Going

AML- Where Are We Now and Where Are We Going

Management of Adverse Events of Check Point Inhibitors (CPI) and Antibody Drug Conjugates (ADC) in Solid Tumors

Management of Adverse Events of Check Point Inhibitors (CPI) and Antibody Drug Conjugates (ADC) in Solid Tumors

The Challenges of Biosimilars in the Daily Oncology Practice?

The Challenges of Biosimilars in the Daily Oncology Practice?

Addressing Social Determinants of Health (SDOH)

Addressing Social Determinants of Health (SDOH)

Liquid Biopsies to Guide Targeted Therapy

Liquid Biopsies to Guide Targeted Therapy